background image

Clinical Trials In Meridian

Discover hundreds of clinical trials in Meridian.
Search clinical trials in Meridian by condition or phase.

e.g. Respiratory Diseases
Meridian•Healthy volunteers: No

A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

Recruiting
PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Boise, Spokane, Salt Lake City, Portlandshow 99 more

Code:

NCT03871257

Conditions

Low Grade Glioma

Neurofibromatosis Type 1

Visual Pathway Glioma

Eligibility Criteria

Sex: All

Age: 2 - 21

Healthy Volunteers: Not accepted

Interventions

Carboplatin

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration

Selumetinib Sulfate

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Recruiting
PHASE3

Sponsor:

SWOG Cancer Research Network

Location:

Nampa, Caldwell, Butte, Loganshow 238 more

Code:

NCT03678025

Conditions

Castration Levels of Testosterone

Metastatic Prostatic Adenocarcinoma

Stage IV Prostate Cancer AJCC v8

Stage IVA Prostate Cancer AJCC v8

Stage IVB Prostate Cancer AJCC v8

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Abiraterone

Bicalutamide

Degarelix

Docetaxel

Flutamide

Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal Epilepsy

Recruiting
PHASE2

Sponsor:

Rapport Therapeutics Inc.

Location:

Boise, Kansas City, Rochester, Houstonshow 6 more

Code:

NCT06377930

Conditions

Focal Onset Seizures

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

RAP-219

Gene Therapy for Haemophilia A.

Recruiting
PHASE1
PHASE2

Sponsor:

University College, London

Location:

Boise, Memphis, Lexington

Code:

NCT03001830

Conditions

Hemophilia A

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

AAV2/8-HLP-FVIII-V3

A Study to Evaluate the Safety of CMTX-101 in People with Cystic Fibrosis

Recruiting
PHASE1
PHASE2

Sponsor:

Clarametyx Biosciences, Inc.

Location:

Boise, Salt Lake City, Seattle, Palo Altoshow 15 more

Code:

NCT06159725

Conditions

Persistent Infection

Cystic Fibrosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CMTX-101

Placebo

Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery

Recruiting
PHASE2

Sponsor:

ECOG-ACRIN Cancer Research Group

Location:

Meridian, Boise, Nampa, Caldwellshow 101 more

Code:

NCT03493425

Conditions

Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7

Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Carboplatin

Cisplatin

Docetaxel

Image Guided Radiation Therapy

Intensity-Modulated Radiation Therapy

Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program

Recruiting
PHASE3

Sponsor:

Alliance for Clinical Trials in Oncology

Location:

Boise, Nampa, Caldwell, Ontarioshow 148 more

Code:

NCT05008848

Conditions

Cigarette Smoking-Related Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Smoking Cessation Intervention

Health Promotion and Education

Informational Intervention

Questionnaire Administration

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study

Recruiting
PHASE3

Sponsor:

Alliance for Clinical Trials in Oncology

Location:

Meridian, Boise, Nampa, Fruitlandshow 90 more

Code:

NCT05673148

Conditions

Metastatic Colorectal Adenocarcinoma

Stage IV Colorectal Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Stereotactic Ablative Radiotherapy

Resection

Microwave Ablation

Chemotherapy

Computed Tomography

S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration

Recruiting
PHASE3

Sponsor:

SWOG Cancer Research Network

Location:

Meridian, Boise, Nampa, Caldwellshow 499 more

Code:

NCT04071457

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Lenalidomide

Daratumumab/rHuPH20

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting
PHASE3

Sponsor:

NRG Oncology

Location:

Meridian, Boise, Nampa, Caldwellshow 629 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression